방사선의학용 AI 시장 예측(-2034년) : 구성 요소, 기술, 도입 형태, 영상 진단법, 용도, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global AI in Radiology Market is accounted for $0.6 billion in 2026 and is expected to reach $3.2 billion by 2034, growing at a CAGR of 23.4% during the forecast period. AI in Radiology is the application of advanced artificial intelligence technologies, including machine learning and deep learning, to support the analysis, interpretation, and management of medical imaging data. It enables automated identification of abnormalities, image enhancement, workflow optimization, and clinical decision support. By processing large volumes of imaging data from modalities such as CT, MRI, and X-rays, AI helps radiologists improve diagnostic accuracy, shorten interpretation time, and enhance patient outcomes through faster and more precise medical imaging insights.

Market Dynamics:

Driver:

Rising medical imaging volumes and radiologist shortages

The exponential growth in medical imaging volumes, coupled with a global shortage of radiologists, is creating an urgent need for AI-powered workflow solutions. AI algorithms excel at triaging critical cases, allowing radiologists to prioritize life-threatening conditions like intracranial hemorrhages or pulmonary embolisms. Furthermore, the push for precision medicine is driving demand for advanced imaging biomarkers and quantitative analysis that AI can provide. The proven ability of AI to reduce turnaround times and improve diagnostic consistency is compelling healthcare providers to integrate these tools into their standard practice, fueling market expansion.

Restraint:

High implementation costs and interoperability challenges

The integration of AI into clinical radiology workflows faces significant hurdles due to high implementation costs and the need for seamless interoperability with existing PACS and EHR systems. Concerns regarding data privacy, cybersecurity, and the ethical implications of algorithmic bias also pose substantial challenges. Furthermore, the lack of standardized regulatory frameworks and reimbursement models for AI-based medical software creates financial uncertainty for developers and adopters. Clinical validation and the need for prospective evidence demonstrating improved patient outcomes remain critical barriers to widespread adoption.

Opportunity:

Value-based care and personalized medicine advancements

The shift toward value-based care presents a significant opportunity for AI in radiology to demonstrate its impact on cost reduction and patient outcomes. AI-driven solutions that automate routine tasks, such as measurement and documentation, free up radiologists to focus on complex cases and direct patient interaction. The development of multimodal AI models that integrate imaging data with genomics and electronic health records offers the potential for groundbreaking advancements in personalized medicine. Emerging markets are also primed for adoption, as they seek to leapfrog traditional infrastructure limitations with scalable, cloud-based AI solutions.

Threat:

Technological obsolescence and cybersecurity risks

The rapid pace of technological advancement in AI poses a threat of obsolescence for established software solutions, requiring continuous R&D investment to remain competitive. An over-reliance on AI without adequate human oversight could lead to diagnostic errors or liability issues, eroding trust in the technology. Additionally, the market is witnessing increasing consolidation, which could limit competition and innovation. Cybersecurity threats targeting interconnected medical devices and AI systems also pose a risk to patient data integrity and hospital operations, necessitating robust protective measures.

Covid-19 Impact:

The COVID-19 pandemic acted as a catalyst for AI adoption in radiology, as healthcare systems faced unprecedented imaging volumes for chest CTs and X-rays. AI tools were rapidly deployed to assist in the detection and quantification of lung abnormalities associated with the virus, alleviating the burden on overstretched radiologists. The crisis accelerated regulatory approvals, with agencies issuing emergency use authorizations for AI-based diagnostic tools. It also highlighted the necessity of remote, cloud-based solutions, fundamentally shifting the market toward digital transformation and decentralized diagnostic workflows.

The software segment is expected to be the largest during the forecast period

The software segment is anticipated to account for the largest market share, driven by the foundational role of algorithms in image analysis, diagnostic support, and workflow automation. These software solutions are essential for converting raw imaging data into actionable clinical insights. The continuous development of sophisticated deep learning models for tasks like lesion detection and organ segmentation is fueling this dominance. As hospitals seek to enhance radiologist efficiency and diagnostic accuracy without significant hardware overhauls, the demand for advanced, integrable software platforms remains exceptionally high.

The cloud-based segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cloud-based deployment segment is predicted to witness the highest growth rate, attributed to its scalability, cost-effectiveness, and ability to facilitate remote collaboration. Cloud platforms enable seamless updates, centralized data management, and the deployment of computational power without substantial on-site IT infrastructure. This model is particularly attractive for smaller imaging centers and hospitals in emerging regions seeking rapid digital transformation. The shift toward teleradiology and the need for accessible AI tools across multiple facilities are further accelerating the adoption of cloud-based solutions.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by its advanced healthcare IT infrastructure, strong presence of key AI developers, and favorable reimbursement landscape. The United States, in particular, leads in the adoption of AI tools across major hospital networks and imaging centers. High R&D investment, a competitive regulatory environment with FDA clearances, and a strong focus on value-based care models that reward efficiency and accuracy collectively solidify the region's dominant position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by rapidly expanding healthcare infrastructure and increasing medical imaging volumes. Countries like China, India, and Japan are investing heavily in digital health initiatives and AI research. The region's large population base, rising prevalence of chronic diseases, and a growing need to address radiologist shortages are driving demand. Government support for AI integration and a burgeoning medical device sector are creating a fertile ground for rapid market expansion.

Key players in the market

Some of the key players in AI in Radiology Market include Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, IBM, NVIDIA, Aidoc, Arterys, Viz.ai, Qure.ai, Enlitic, Lunit, Zebra Medical Vision, iCAD, and Infervision.

Key Developments:

In March 2026, IBM and ETH Zurich announced a 10-year collaboration to advance the next generation of algorithms at the intersection of AI and quantum computing. This initiative represents the latest milestone in the long-standing collaboration between the two institutions, further strengthening a scientific exchange that has helped create the future of information technology.

In March 2026, NVIDIA and Marvell Technology, Inc. announced a strategic partnership to connect Marvell to the NVIDIA AI factory and AI-RAN ecosystem through NVIDIA NVLink Fusion(TM), offering customers building on NVIDIA architectures greater choice and flexibility in developing next-generation infrastructure. The companies will also collaborate on silicon photonics technology.

Components Covered:

• Software
• Hardware
• Services

Technologies Covered:

• Machine Learning
• Deep Learning
• Natural Language Processing (NLP)
• Computer Vision
• Context-Aware Computing

Deployment Modes Covered:

• On-Premises
• Cloud-Based
• Hybrid Deployment

Imaging Modalities Covered:

• X-Ray
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound
• Mammography
• Positron Emission Tomography (PET)

Applications Covered:

• Detection & Diagnosis
• Image Segmentation & Quantification
• Workflow Optimization & Triage
• Predictive & Prognostic Analytics
• Treatment Planning
• Monitoring & Follow-Up
• Other Applications

End Users Covered:

• Hospitals & Clinics
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Academic & Research Institutes
• Other End Users

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global AI in Radiology Market, By Component

• 5.1 Software
  • 5.1.1 Image Analysis Software
  • 5.1.2 Diagnostic Support Software
  • 5.1.3 Workflow Automation Software
• 5.2 Hardware
  • 5.2.1 AI-Enabled Imaging Systems
  • 5.2.2 Edge Computing Devices
• 5.3 Services
  • 5.3.1 Integration & Deployment
  • 5.3.2 Training & Consulting
  • 5.3.3 Maintenance & Support

6 Global AI in Radiology Market, By Technology

• 6.1 Machine Learning
• 6.2 Deep Learning
• 6.3 Natural Language Processing (NLP)
• 6.4 Computer Vision
• 6.5 Context-Aware Computing

7 Global AI in Radiology Market, By Deployment Mode

• 7.1 On-Premises
• 7.2 Cloud-Based
• 7.3 Hybrid Deployment

8 Global AI in Radiology Market, By Imaging Modality

• 8.1 X-Ray
• 8.2 Computed Tomography (CT)
• 8.3 Magnetic Resonance Imaging (MRI)
• 8.4 Ultrasound
• 8.5 Mammography
• 8.6 Positron Emission Tomography (PET)

9 Global AI in Radiology Market, By Application

• 9.1 Detection & Diagnosis
• 9.2 Image Segmentation & Quantification
• 9.3 Workflow Optimization & Triage
• 9.4 Predictive & Prognostic Analytics
• 9.5 Treatment Planning
• 9.6 Monitoring & Follow-Up
• 9.7 Other Applications

10 Global AI in Radiology Market, By End User

• 10.1 Hospitals & Clinics
• 10.2 Diagnostic Imaging Centers
• 10.3 Ambulatory Surgical Centers
• 10.4 Academic & Research Institutes
• 10.5 Other End Users

11 Global AI in Radiology Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 Siemens Healthineers
• 14.2 GE HealthCare
• 14.3 Philips Healthcare
• 14.4 Canon Medical Systems
• 14.5 IBM
• 14.6 NVIDIA
• 14.7 Aidoc
• 14.8 Arterys
• 14.9 Viz.ai
• 14.10 Qure.ai
• 14.11 Enlitic
• 14.12 Lunit
• 14.13 Zebra Medical Vision
• 14.14 iCAD
• 14.15 Infervision